Addressing high cervical cancer rates in the Rio Grande Valley along the Texas–Mexico border: a community-based initiative focused on education,patient navigation,and medical provider training/telementoring

Abstract

Aims:

Cervical cancer incidence and mortality rates are approximately 55% higher in the Rio Grande Valley (RGV) along the Texas–Mexico border compared with the average rates in the US. Our aim was to improve cervical cancer prevention efforts in the RGV through a comprehensive multilevel intervention initiative focused on community education, patient navigation, and training of local providers.

Methods:

We initiated a program in the RGV which consisted of (1) community education, (2) patient navigation, and (3) a training/mentoring program for local medical providers including hands-on training courses coupled with telementoring using Project ECHO® (Extension for Community Health Outcomes). We assessed the number of women undergoing cervical cancer screening, diagnosis, and treatment at three participating clinics caring for underserved women in the region.

Results:

From November 2014 to October 2018, 14,846 women underwent cervical cancer screening. A total of 2030 (13.7%) women underwent colposcopy for abnormal results (179% increase over baseline) and 453 women underwent loop electrosurgical excision procedures (LEEPs) for treatment of cervical dysplasia. Invasive cancer was diagnosed in 39 women who were navigated to a gynecologic oncologist for treatment. Seven local medical providers were trained to perform colposcopy and/or LEEP. Project ECHO telementoring videoconferences were held every 2 weeks for a total 101 sessions with an average of 22 participants per session and a total of 180 patient cases presented and discussed.

Conclusions:

Our program led to a large number of women undergoing diagnosis and treatment of cervical dysplasia in the RGV. If sustained, we anticipate these efforts will decrease cervical cancer rates in the region. The program is currently being expanded to additional underserved areas of Texas and globally to low- and middle-income countries.

Keywords

cervical cancer screening prevention human papillomavirus (HPV)telementoring

Get full access to this article

View all access options for this article.

References

Arbyn

Weiderpass

Bruni

et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020; 8(2): e191–203.

Bray

Ferlay

Soerjomataram

et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394–424.

Texas Department of State Health Services. Texas cancer registry 2020. Available online at: https://www.dshs.texas.gov/ (last accessed 3 May 2020).

National Cancer Institute. Cancer stat facts: cervix uteri cancer. 2020.

U.S. Census Bureau. Available online at: https://www.census.gov/ (last accessed 25 February 2021).

Health Resources & Services Administration. Available online at: https://data.hrsa.gov/tools/shortage-area/hpsa-find (last accessed 6 March 2021).

Walboomers

Jacobs

Manos

et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1): 12–9.

Walker

Elam-Evans

Yankey

et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years – United States, 2018. MMWR Morb Mortal Wkly Rep 2019; 68(33): 718–23.

Papanicolaou

GN.

A new procedure for staining vaginal smears. Science 1942; 95(2469): 438–9.

10.

Perkins

Guido

Castle

et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24(2): 102–31.

11.

Saslow

Solomon

Lawson

et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012; 137(4): 516–42.

12.

American Society of Colposcopy and Cervical Pathology. 2020. Available online at: https://www.asccp.org/ (last accessed 25 February 2021).

13.

Parra

Oden

Schmeler

et al. Low-cost instructional apparatus to improve training for cervical cancer screening and prevention. Obstet Gynecol 2019; 133(3): 559–67.

14.

Arora

Thornton

Murata

et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011; 364(23): 2199–207.

15.

Lopez

Baker

Milbourne

et al. Project ECHO: a telementoring program for cervical cancer prevention and treatment in low-resource settings. J Glob Oncol 2017; 3(5): 658–65.

16.

Cira

Tesfay

Zujewski

et al. Promoting evidence-based practices for breast cancer care through web-based collaborative learning. J Cancer Policy 2020; 25:100242.

17.

Harris

Taylor

Thielke

et al. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377–81.

18.

Cremer

Maza

Alfaro

et al. Introducing a high-risk HPV DNA test into a public sector screening program in El Salvador. J Low Genit Tract Dis 2016; 20(2): 145–50.

19.

White

Meglioli

Chowdhury

et al. Integrating cervical cancer screening and preventive treatment with family planning and HIV-related services. Int J Gynaecol Obstet 2017; 138(Suppl. 1): 41–6.

20.

Boom

Lopez

Daheri

et al. Perspectives on cervical cancer screening and prevention: challenges faced by providers and patients along the Texas-Mexico border. Perspect Public Health 2019; 139(4): 199–205.